Osteoporosis is silent until it breaks a bone — and then it changes everything.

Bone is not a static structure. It is a living tissue that undergoes continuous remodeling throughout life — a coordinated cycle in which osteoclasts resorb old bone and osteoblasts lay down new bone in its place. This process repairs microdamage, adapts bone to mechanical loads, and releases calcium as needed. In healthy adults, resorption and formation are balanced, and bone mass is maintained.

Peak bone mass — the maximum bone density a person ever achieves — is reached in the mid-twenties, and it is determined largely by genetics, sex, nutrition, and physical activity. After age 30, bone mass slowly declines in both sexes. In women, this decline accelerates dramatically after menopause, when falling estrogen levels remove the suppressive effect that estrogen normally has on osteoclast activity. This is why the majority of osteoporosis cases occur in postmenopausal women — but men are affected too, typically later in life, and male osteoporosis is consistently underdiagnosed and undertreated.

The structural consequence is loss of both cortical and trabecular bone. Trabecular bone — the spongy inner network of plates and struts found in the vertebrae, hip, and wrist — loses connectivity, with thinning and perforation of individual struts. This is why fragility fractures cluster at those specific sites: the vertebral bodies, hip, and distal radius. Cortical bone — the dense outer shell of long bones — also thins with age, further reducing bone strength beyond what density alone would predict. This is why a patient's bone quality, not just density, matters in fracture prediction.

Many conditions and medications accelerate bone loss. Glucocorticoids — even at moderate doses — are the most common secondary cause. Other contributors include hypogonadism, hyperthyroidism, hyperparathyroidism, malabsorption (celiac, IBD, bariatric surgery), chronic kidney disease, smoking, excessive alcohol, and certain medications (aromatase inhibitors, androgen deprivation therapy, proton pump inhibitors with long-term use, and some anticonvulsants). Type 2 diabetes is increasingly recognized as a risk factor for fracture independent of BMD — which means that patients managing diabetes should be evaluated for bone health as part of their overall chronic disease care. A reference on metformin for diabetes illustrates how chronic diseases often cluster, and why coordinated management matters.

Calcium. The recommended daily intake for adults 50+ is 1200 mg — preferably from dietary sources (dairy, leafy greens, fortified foods, almonds, sardines). Dietary calcium is preferred over supplements because of superior absorption and the lack of association with the small cardiovascular signal seen in some supplemental calcium studies. If supplements are needed, take calcium citrate (better absorbed in low-acid states) or calcium carbonate with food (better absorbed in normal acid), 500 mg at a time. Higher single doses are poorly absorbed.

Vitamin D. The recommended intake for most adults is 800–1000 IU daily, though many patients require higher doses to achieve a serum 25-hydroxyvitamin D level of at least 30 ng/mL. Vitamin D deficiency is very common in the U.S. — particularly in older adults, those with limited sun exposure, and patients with malabsorption — and can cause bone loss, muscle weakness, and increased fall risk. A level below 20 ng/mL is frankly deficient; 20–30 ng/mL is insufficient for bone health. For patients with severe deficiency, higher weekly doses are used to replete stores before maintenance dosing.

Weight-bearing and resistance exercise. Exercise is not optional. Weight-bearing activity — walking, jogging, stair climbing — and resistance training stimulate bone formation and improve strength, balance, and muscle mass — all of which reduce fall and fracture risk. Balance training (tai chi, physical therapy) is particularly important in older adults. Exercise should be tailored to the patient's fracture risk and fall risk — very high-impact activity may not be appropriate for someone with established vertebral fractures.

Fall prevention. Most fractures occur after a fall. Reducing fall risk — through home safety assessment, medication review (particularly sedatives and antihypertensives), vision correction, and strength/balance training — is as important as any medication. Patients with osteoporosis should be counseled about fall prevention at every visit. And for patients managing diabetes and other chronic conditions that contribute to neuropathy or vision changes, the fall risk assessment should be part of coordinated chronic disease care. A reference on Metformin interactions illustrates how routine medication review can catch issues — including fall-risk medications — that patients often overlook.

Oral bisphosphonates are generic and inexpensive. Alendronate, risedronate, and ibandronate cost a few dollars to $30 per month at U.S. pharmacies — often on $4 lists. Zoledronic acid (Reclast) as an annual IV infusion is more expensive per dose but cost-effective over a year. Calcium and vitamin D supplements are inexpensive and widely available over the counter.

Denosumab (Prolia) is brand-only and priced at roughly $1,500–$2,000 per year in the U.S., with biosimilars expected in the coming years. Anabolic agents (teriparatide, abaloparatide, romosozumab) are significantly more expensive — typically $15,000–$25,000 per year — and require prior authorization for insurance coverage. They are generally reserved for severe disease and are usually covered when the clinical criteria are met.

Medicare Part D covers osteoporosis medications, and the 2025 redesign caps annual out-of-pocket costs at $2,000 — a substantial improvement for patients on multiple chronic medications. Manufacturer copay assistance programs are available for denosumab and the anabolic agents, and foundation grants help patients with high copays. For patients on multiple chronic medications — including for diabetes, hypertension, and dyslipidemia, which commonly coexist with osteoporosis — pharmacy-level pricing on generics still matters. A live comparison across licensed U.S. sellers, like the one shown for affordable Metformin online, illustrates the same pricing dynamics that apply to any generic medication.

DXA screening is covered by Medicare every 2 years for eligible patients, and by most commercial plans. FRAX is free to use online. Falls prevention programs are available in most communities through Area Agencies on Aging. For patients new to comparing prescription prices or filling prescriptions online, the standards that apply are documented in this reference on buy Metformin with prescription online — prescription first, licensed seller second, small first order third.